CorMedix (CRMD) Cash from Investing Activities (2010 - 2025)

CorMedix has disclosed Cash from Investing Activities across 12 years of filings, most recently posting $3.3 million for Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at $3.3 million, up 1185.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$308.4 million (down 1552.73% YoY), and the FY2025 annual result was -$308.4 million, down 1552.73% from the prior year.
• Cash from Investing Activities came in at $3.3 million for Q4 2025 at CorMedix, up from -$291.3 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $8.9 million in Q1 2024 to a low of -$291.3 million in Q3 2025.
• The 5-year median for Cash from Investing Activities is -$256074.5 (2021), against an average of -$15.9 million.
• Across the five-year window, Cash from Investing Activities soared 32222.08% in 2023 and tumbled 4708.5% in 2025, its largest moves.
• CorMedix's Cash from Investing Activities stood at -$7.1 million in 2021, then soared by 99.97% to -$1861.0 in 2022, then jumped by 32222.08% to $597792.0 in 2023, then sank by 150.83% to -$303874.0 in 2024, then jumped by 1185.0% to $3.3 million in 2025.
• The last three Cash from Investing Activities figures came in at $3.3 million (Q4 2025), -$291.3 million (Q3 2025), and -$20.2 million (Q2 2025), per Business Quant data.